235 related articles for article (PubMed ID: 12736278)
1. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.
Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Bulun SE
N Engl J Med; 2003 May; 348(19):1855-65. PubMed ID: 12736278
[TBL] [Abstract][Full Text] [Related]
2. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.
Demura M; Martin RM; Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Mendonca BB; Hanaki K; Kanzaki S; Rhoads DB; Misra M; Bulun SE
Hum Mol Genet; 2007 Nov; 16(21):2529-41. PubMed ID: 17584767
[TBL] [Abstract][Full Text] [Related]
3. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
4. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred.
Binder G; Iliev DI; Dufke A; Wabitsch M; Schweizer R; Ranke MB; Schmidt M
J Clin Endocrinol Metab; 2005 Jan; 90(1):484-92. PubMed ID: 15483104
[TBL] [Abstract][Full Text] [Related]
5. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.
Bulun SE; Lin Z; Imir G; Amin S; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Gurates B; Tamura M; Langoi D; Deb S
Pharmacol Rev; 2005 Sep; 57(3):359-83. PubMed ID: 16109840
[TBL] [Abstract][Full Text] [Related]
6. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
7. Organization of the human aromatase p450 (CYP19) gene.
Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
[TBL] [Abstract][Full Text] [Related]
8. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization.
Spratt DI; Morton JR; Kramer RS; Mayo SW; Longcope C; Vary CP
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E631-8. PubMed ID: 16670151
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.
Agarwal VR; Takayama K; Van Wyk JJ; Sasano H; Simpson ER; Bulun SE
J Clin Endocrinol Metab; 1998 May; 83(5):1797-800. PubMed ID: 9589695
[TBL] [Abstract][Full Text] [Related]
10. Porcine hypothalamic aromatase cytochrome P450: isoform characterization, sex-dependent activity, regional expression, and regulation by enzyme inhibition in neonatal boars.
Corbin CJ; Berger T; Ford JJ; Roselli CE; Sienkiewicz W; Trainor BC; Roser JF; Vidal JD; Harada N; Conley AJ
Biol Reprod; 2009 Aug; 81(2):388-95. PubMed ID: 19403926
[TBL] [Abstract][Full Text] [Related]
11. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription.
Stratakis CA; Vottero A; Brodie A; Kirschner LS; DeAtkine D; Lu Q; Yue W; Mitsiades CS; Flor AW; Chrousos GP
J Clin Endocrinol Metab; 1998 Apr; 83(4):1348-57. PubMed ID: 9543166
[TBL] [Abstract][Full Text] [Related]
12. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
13. A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome.
Tiulpakov A; Kalintchenko N; Semitcheva T; Polyakov A; Dedov I; Sverdlova P; Kolesnikova G; Peterkova V; Rubtsov P
J Clin Endocrinol Metab; 2005 Jul; 90(7):4184-90. PubMed ID: 15811932
[TBL] [Abstract][Full Text] [Related]
14. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
15. Novel promoter I.8 and promoter usage in the CYP19 (aromatase) gene.
Demura M; Reierstad S; Innes JE; Bulun SE
Reprod Sci; 2008 Dec; 15(10):1044-53. PubMed ID: 18955734
[TBL] [Abstract][Full Text] [Related]
16. Massive extranglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy.
Hemsell DL; Edman CD; Marks JF; Siiteri PK; MacDonald PC
J Clin Invest; 1977 Aug; 60(2):455-64. PubMed ID: 874104
[TBL] [Abstract][Full Text] [Related]
17. Endocrine disorders associated with inappropriately high aromatase expression.
Bulun SE; Noble LS; Takayama K; Michael MD; Agarwal V; Fisher C; Zhao Y; Hinshelwood MM; Ito Y; Simpson ER
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):133-9. PubMed ID: 9365182
[TBL] [Abstract][Full Text] [Related]
18. Aromatase expression in health and disease.
Simpson ER; Zhao Y; Agarwal VR; Michael MD; Bulun SE; Hinshelwood MM; Graham-Lorence S; Sun T; Fisher CR; Qin K; Mendelson CR
Recent Prog Horm Res; 1997; 52():185-213; discussion 213-4. PubMed ID: 9238853
[TBL] [Abstract][Full Text] [Related]
19. A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue.
Zhao H; Innes J; Brooks DC; Reierstad S; Yilmaz MB; Lin Z; Bulun SE
Reprod Biol Endocrinol; 2009 Apr; 7():37. PubMed ID: 19393092
[TBL] [Abstract][Full Text] [Related]
20. In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer.
Dowsett M; Jones A; Johnston SR; Jacobs S; Trunet P; Smith IE
Clin Cancer Res; 1995 Dec; 1(12):1511-5. PubMed ID: 9815951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
